 MONMOUTH JUNCTION, N.J., May 19, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a critical care leader commercializing its CytoSorb blood purification technology to treat deadly conditions in critically ill and cardiac surgery patients around the world, announces that the Company will present an overview of the Companys progress and outlook at the UBS Global Healthcare Virtual Conference and provide a prerecorded presentation at the Oppenheimer MedTech, Tools and Diagnostic Summit on Wednesday, May 26, 2021. 